azacitidine,venetoclax
abbvie,roche
['leukemia', 'venetoclax', 'azacitidine,(-oral azaci),(-azacitidine oral)', 'aza ', '+aza', 'leusm']
#ash22 #leusm d hner: response rates similar when using eln 2017 v 2022 criteria but 2017 and 2022 do not provide meaningful risk prediction with aza/ven therapy. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)